Distinguished in Asphyxia Neonatorum

Nicola J. Robertson

Oriflame R&D, Bray Business Park, A98 Y6W0, 
Bray, L, IE 
Distinguished in Asphyxia Neonatorum
Oriflame R&D, Bray Business Park, A98 Y6W0, 
Bray, L, IE 
OverviewLocationsClinical Research

Overview

Nicola Robertson practices in Bray, Ireland. Ms. Robertson is rated as a Distinguished expert by MediFind in the treatment of Asphyxia Neonatorum. Her top areas of expertise are Hypothermia, Asphyxia Neonatorum, Cerebral Hypoxia, Premature Infant, and Thrombectomy.

Her clinical research consists of co-authoring 185 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 23 articles and participated in 1 clinical trial in the study of Asphyxia Neonatorum.

Gender
Female

Locations

Oriflame R&D, Bray Business Park, A98 Y6W0, Bray, L, Ireland
Other Locations
R&d, Bray, L, Ireland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

SURV1VE-Trial - Sustained Inflation and Chest Compression Versus 3:1 Chest Compression to Ventilation Ratio During Cardiopulmonary Resuscitation of Asphyxiated Newborns: A Randomized Controlled Trial
SURV1VE-Trial - Sustained Inflation and Chest Compression Versus 3:1 Chest Compression to Ventilation Ratio During Cardiopulmonary Resuscitation of Asphyxiated Newborns: A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: August 29, 2024
Intervention Type: Procedure
Study Phase: Not Applicable

185 Total Publications

Acute High Dose Melatonin for Encephalopathy of the Newborn (ACUMEN) Study: a protocol for a multicentre phase 1 safety trial of melatonin to augment therapeutic hypothermia for moderate/severe hypoxic ischaemic encephalopathy.
Acute High Dose Melatonin for Encephalopathy of the Newborn (ACUMEN) Study: a protocol for a multicentre phase 1 safety trial of melatonin to augment therapeutic hypothermia for moderate/severe hypoxic ischaemic encephalopathy.
Journal: BMJ open
Published: August 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Robertson's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile